title: Mangiferin, an anti-HIV-1 agent targeting protease and effective against resistant strains.
abstract: The anti-HIV-1 activity of mangiferin was evaluated. Mangiferin can inhibit HIV-1(Ⅲ)(B) induced syncytium formation at non-cytotoxic concentrations, with a 50% effective concentration (EC₅₀) at 16.90 μM and a therapeutic index (TI) above 140. Mangiferin also showed good activities in other laboratory-derived strains, clinically isolated strains and resistant HIV-1 strains. Mechanism studies revealed that mangiferin might inhibit the HIV-1 protease, but is still effective against HIV peptidic protease inhibitor resistant strains. A combination of docking and pharmacophore methods clarified possible binding modes of mangiferin in the HIV-1 protease. The pharmacophore model of mangiferin consists of two hydrogen bond donors and two hydrogen bond acceptors. Compared to pharmacophore features found in commercially available drugs, three pharmacophoric elements matched well and one novel pharmacophore element was observed. Moreover, molecular docking analysis demonstrated that the pharmacophoric elements play important roles in binding HIV-1 protease. Mangiferin is a novel nonpeptidic protease inhibitor with an original structure that represents an effective drug development strategy for combating drug resistance.
authors: Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China.
authors: Rui-Rui
authors: RR
authors: Wang
authors: Yue-Dong
authors: YD
authors: Gao
authors: Chun-Hui
authors: CH
authors: Ma
authors: Xing-Jie
authors: XJ
authors: Zhang
authors: Cheng-Gang
authors: CG
authors: Huang
authors: Jing-Fei
authors: JF
authors: Huang
authors: Yong-Tang
authors: YT
authors: Zheng
references: Pharmacol Res. 2000 Dec;42(6):565-73
references: 11058410
references: Pharmacol Res. 2004 Aug;50(2):165-72
references: 15177305
references: Nature. 1995 Apr 6;374(6522):569-71
references: 7700387
references: J Comput Chem. 2003 Oct;24(13):1549-62
references: 12925999
references: N Engl J Med. 2004 Mar 4;350(10):1023-35
references: 14999114
references: Protein Sci. 2006 Nov;15(11):2507-24
references: 17075131
references: Phytomedicine. 2000 Jan;6(6):411-9
references: 10715843
references: Eur J Pharmacol. 2005 Apr 18;513(1-2):47-55
references: 15878708
references: J Virol. 2007 May;81(10):5144-54
references: 17360759
references: Chemotherapy. 1996 Nov-Dec;42(6):443-51
references: 8957579
references: Zhongguo Yao Li Xue Bao. 1993 Sep;14(5):452-4
references: 8010041
references: Chin Med J (Engl). 1990 Feb;103(2):160-5
references: 2167819
references: J Ethnopharmacol. 2001 Dec;78(2-3):133-7
references: 11694357
references: Lancet. 2003 Dec 13;362(9400):2002-11
references: 14683662
references: Antimicrob Agents Chemother. 1997 May;41(5):1058-63
references: 9145869
references: J Chem Inf Model. 2005 Mar-Apr;45(2):422-30
references: 15807508
references: Biochem Biophys Res Commun. 2004 Nov 12;324(2):605-10
references: 15474470
references: J Hepatol. 2006;44(1 Suppl):S100-3
references: 16359748
references: Adv Virus Res. 2009;73:1-53
references: 19695380
references: N Engl J Med. 2001 Feb 15;344(7):472-80
references: 11172188
references: J Ethnopharmacol. 2008 May 8;117(2):249-56
references: 18343612
references: N Engl J Med. 2002 Aug 8;347(6):385-94
references: 12167680
references: Antimicrob Agents Chemother. 1998 Nov;42(11):2775-83
references: 9797203
references: J Chem Inf Comput Sci. 1996 May-Jun;36(3):563-71
references: 8690757
references: Biochemistry. 1995 Jul 25;34(29):9282-7
references: 7626598
references: Biochem Biophys Res Commun. 2007 Apr 20;355(4):1091-5
references: 17336271
references: Toxicology. 2002 Jul 15;176(3):165-73
references: 12093613
references: Antimicrob Agents Chemother. 1995 Aug;39(8):1704-10
references: 7486905
references: Phytomedicine. 2005 Mar;12(3):209-15
references: 15830843
references: Protein Sci. 2007 Sep;16(9):2030-41
references: 17766392
references: Biochem Biophys Res Commun. 2009 May 8;382(3):540-4
references: 19289098
references: Curr Protoc Bioinformatics. 2006 Oct;Chapter 5:Unit-5.6
references: 18428767
references: Lancet. 2005 Mar 19-25;365(9464):1031-8
references: 15781098
references: Int Immunopharmacol. 2004 Jun;4(6):763-78
references: 15135318